Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 4 | $60,700,210 |
Sells | 129 | $20,005,523 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
24 May 2024 16:10 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 22 May 2024 | Sale | 3,242 | 29.65 | 96,125 | D |
24 May 2024 16:13 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 22 May 2024 | Sale | 3,247 | 29.65 | 96,274 | D |
24 May 2024 16:14 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 22 May 2024 | Sale | 3,247 | 29.65 | 96,274 | D |
24 May 2024 16:15 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 22 May 2024 | Sale | 16,163 | 29.65 | 479,233 | D |
24 May 2024 16:18 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 22 May 2024 | Sale | 4,042 | 29.65 | 119,845 | D |
10 Jul 2024 17:04 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 09 Jul 2024 | Sale | 4,619 | 28.06 | 129,609 | D |
10 Jul 2024 17:06 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 09 Jul 2024 | Sale | 1,527 | 28.06 | 42,848 | D |
10 Jul 2024 17:07 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 09 Jul 2024 | Sale | 4,747 | 28.06 | 133,201 | D |
19 Jul 2024 17:36 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 17 Jul 2024 | Sale | 510 | 30.55 | 15,580 | D |
19 Jul 2024 17:36 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 17 Jul 2024 | Sale | 8,175 | 29.64 | 242,307 | D |
19 Jul 2024 17:38 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 17 Jul 2024 | Sale | 169 | 30.55 | 5,163 | D |
19 Jul 2024 17:38 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 17 Jul 2024 | Sale | 2,698 | 29.64 | 79,969 | D |
19 Jul 2024 17:39 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 17 Jul 2024 | Sale | 184 | 30.55 | 5,621 | D |
19 Jul 2024 17:39 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 17 Jul 2024 | Sale | 2,939 | 29.64 | 87,112 | D |
19 Jul 2024 17:41 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 17 Jul 2024 | Sale | 504 | 29.64 | 14,939 | D |
19 Jul 2024 17:41 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 17 Jul 2024 | Sale | 31 | 30.55 | 947 | D |
19 Jul 2024 17:41 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 17 Jul 2024 | Sale | 147 | 30.55 | 4,491 | D |
19 Jul 2024 17:41 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 17 Jul 2024 | Sale | 2,362 | 29.64 | 70,010 | D |
19 Jul 2024 17:42 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 17 Jul 2024 | Sale | 147 | 30.55 | 4,491 | D |
19 Jul 2024 17:42 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 17 Jul 2024 | Sale | 2,358 | 29.64 | 69,891 | D |
26 Jul 2024 16:17 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 24 Jul 2024 | Sale | 4,015 | 27.76 | 111,456 | D |
26 Jul 2024 16:19 | IMVT | Immunovant Inc | GEFFNER MICHAEL | Chief Medical Officer | 24 Jul 2024 | Sale | 3,456 | 27.76 | 95,939 | D |
26 Jul 2024 16:20 | IMVT | Immunovant Inc | STOUT JAY S | Chief Technology Officer | 24 Jul 2024 | Sale | 2,813 | 27.76 | 78,089 | D |
23 Aug 2024 16:07 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 21 Aug 2024 | Sale | 598 | 32.32 | 19,327 | D |
23 Aug 2024 16:07 | IMVT | Immunovant Inc | SALZMANN PETER | Chief Executive Officer | 21 Aug 2024 | Sale | 14,470 | 31.84 | 460,725 | D |
23 Aug 2024 16:10 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 21 Aug 2024 | Sale | 120 | 32.32 | 3,878 | D |
23 Aug 2024 16:10 | IMVT | Immunovant Inc | BUTCHKO JULIA G. | Chief Development Officer | 21 Aug 2024 | Sale | 2,907 | 31.84 | 92,559 | D |
23 Aug 2024 16:11 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 21 Aug 2024 | Sale | 149 | 32.32 | 4,816 | D |
23 Aug 2024 16:11 | IMVT | Immunovant Inc | BARNETT EVA RENEE | Chief Financial Officer | 21 Aug 2024 | Sale | 3,619 | 31.84 | 115,229 | D |
23 Aug 2024 16:14 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 21 Aug 2024 | Sale | 120 | 32.32 | 3,878 | D |
23 Aug 2024 16:14 | IMVT | Immunovant Inc | MACIAS WILLIAM L. | Chief Medical Officer | 21 Aug 2024 | Sale | 2,907 | 31.84 | 92,559 | D |
23 Aug 2024 16:15 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 21 Aug 2024 | Sale | 3,164 | 31.84 | 100,742 | D |
23 Aug 2024 16:15 | IMVT | Immunovant Inc | LEVINE MARK S. | Chief Legal Officer | 21 Aug 2024 | Sale | 131 | 32.32 | 4,234 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)